Here are four points:
1. Zacks presently has a $5.25 price target on EndoChoice stock.
2. EndoChoice has a 50-day moving average price of $4.78 and a 200-day moving average price of $8.50.
3. The company has a 12-month low of $3.70 and a 12-month high of $19.69.
4. The company’s market cap is $124.72 million.
More articles on GI/endoscopy:
4 GI physicians in the news — March 25, 2016
Dr. Gregory Scheible 1st in Indiana to implant Orbera intragastric balloon: 4 points
Emails show Olympus hiked up duodenoscope price 28% after CRE outbreak at UCLA: 8 key notes
